<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02337348</url>
  </required_header>
  <id_info>
    <org_study_id>2013/1653/REK</org_study_id>
    <nct_id>NCT02337348</nct_id>
  </id_info>
  <brief_title>Prospective Randomized Optical Coherence Tomography Oslo tRial</brief_title>
  <acronym>PROCTOR</acronym>
  <official_title>Optical Coherence Tomography (OCT) Guided Compared to Conventional Angiography Guided Coronary Intervention in Stentfailure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oslo University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Oslo University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Coronary artery intervention with stents is a routine procedure with several clinical
      indications. A stentfailure, ie stentrestenosis and/or stentthrombosis will occur in some
      patients. Several different mechanisms have been suggested. Stentfailure may be caused by
      mechanical properties of the stent. This may be secondary to suboptimal stentimplantation, ie
      over/undersizing or acquired ie malapposition or stentfracture. These stentproperties may be
      difficult to identify with conventional coronary angiography due to low image resolution. The
      hypothesis of the study is that high resolution imaging with optical coherence tomography
      (oct) will improve diagnosis and enable a more specific or tailored treatment with a
      subsequent reduction in later stentfailure.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The hypothesis of the PROCTOR study is that high resolution imaging with optical coherence
      tomography (oct) will improve diagnosis and enable a more specific or tailored treatment in
      stent failure. However, the prevalence of stentfailure (ie stent malapposition,
      stentfracture, stentedgedissections etc) not causing clinical endpoints is not known. In a
      subset of patients (n=100) with previously implanted stents performing a new coronary
      angiography based on clinical indication, functional or patent stents (decided by Heart team)
      will be characterized with OCT and the patients followed for 5 years. The purpose of this
      substudy, OCT IPS (OCT In Patent Stents), is to estimate the prevalence of stentpathology in
      patent or functional stents and compare findings with the active arm of PROCTOR.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Stopped due to slow inclusion
  </why_stopped>
  <start_date>August 2014</start_date>
  <completion_date type="Actual">January 31, 2019</completion_date>
  <primary_completion_date type="Actual">January 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Target lesion revascularisation</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>non-fatal myocardial infarction</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiovascular mortality</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Change in kidney function</measure>
    <time_frame>5 years</time_frame>
    <description>Number of participants with more than 25% increase in serum creatinin.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">163</enrollment>
  <condition>Myocardial Infarction</condition>
  <condition>Angina</condition>
  <arm_group>
    <arm_group_label>OCT guided coronary intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Coronary angiography and optical coherence tomography imaging</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional coronary intervention</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Coronary angiography</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Optical coherence tomography</intervention_name>
    <description>Preintervention imaging</description>
    <arm_group_label>OCT guided coronary intervention</arm_group_label>
    <other_name>OCT</other_name>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Coronary angiography</intervention_name>
    <description>Conventional coronary intervention</description>
    <arm_group_label>Conventional coronary intervention</arm_group_label>
    <arm_group_label>OCT guided coronary intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Clinical indication for coronary angiography and intervention due to stentfailure, both
        stentrestenosis and stentthrombosis in stable patients or unstable patients with acute
        coronary syndrome.

        Exclusion Criteria:

          -  Patient not able to give informed consent.

          -  Unwillingness.

          -  Life expectancy &lt; 5 years.

          -  Reduced kidney function with GRF&lt;45.

          -  Coronary artery diameter &lt; 2.5mm.

          -  Pregnancy.

          -  Patients without 11-digit Norwegian personal number.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eigil Fossum, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Oslo University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Oslo university hospital</name>
      <address>
        <city>Oslo</city>
        <zip>0447</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>December 23, 2014</study_first_submitted>
  <study_first_submitted_qc>January 8, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 13, 2015</study_first_posted>
  <last_update_submitted>August 29, 2019</last_update_submitted>
  <last_update_submitted_qc>August 29, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 3, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Oslo University Hospital</investigator_affiliation>
    <investigator_full_name>Eigil Fossum</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>coronary stents</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

